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Abstract 33 
Enabling informed choice is an essential component of care when offering young adults 34 
presymptomatic testing for a genetic condition. A systematic review on this topic 35 
revealed that many young adults grew up with little information regarding their genetic 36 
risk and that parents had applied pressure to them during the testing decision-making 37 
process. However, none of the studies retrieved were conducted in South-European 38 
countries. To address this gap, we undertook a qualitative study based on grounded 39 
theory to explore the psychosocial implications of presymptomatic testing for hereditary 40 
cancer in Italian young adults aged 18-30 years. Interviews were conducted on three 41 
occasions: one month before counselling, and two weeks and six months after results. 42 
Data were coded and grouped under themes. A total of 42 interviews were conducted. 43 
Four themes emerged: knowledge, genetic counselling process, decision-making and 44 
dealing with test results. Although participants grew up with little or no information 45 
about their genetic risk, none expressed regret at having the test at a young age. Pre-test 46 
counselling was appreciated as a source of information, rather than support for decision-47 
making. Decisions were often made autonomously and sometimes conflicted with 48 
parents’ wishes. Participants reported no changes in health behaviours after testing. This 49 
evidence highlights the need for a comprehensive, longitudinal counselling process with 50 
appropriate timing and setting, which supports ‘parent-to-offspring’ risk communication 51 
first and decision-making by young adults about presymptomatic testing and risk 52 
management afterwards. Concluding, it is clear that counselling approaches for 53 
presymptomatic testing may require modification both for young adults and their 54 
parents. 55 
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INTRODUCTION 60 
Presymptomatic genetic testing (PST) involves testing to determine if a person has 61 
inherited a gene variant that causes a condition known to be present in the family, 62 
before they exhibit any signs or symptoms of the condition. Those at risk of heritable 63 
genetic disorders, including hereditary cancer syndromes1 may be able to access PST to 64 
determine their genetic status and potentially alter lifestyle choices or seek early 65 
treatment for symptoms2,3.. Presymptomatic testing of minors (under the age of 18 66 
years) in this situation is not usually recommended4,5, although the age at which young 67 
people should be able to undergo PST for adult-onset disorders is a matter of debate5,6. 68 
Key challenges that typically have to be faced during the transition from adolescence to 69 
adulthood include marriage, completing education, beginning full-time employment and 70 
becoming a parent: the impact of testing may affect, and be affected by, each of these 71 
events.   72 
A variety of psychosocial responses have been observed in those who have chosen to be 73 
tested7. The appropriate age to offer PST is a matter of debate: it is suggested that 74 
undergoing PST too early in life may increase the risk of unfavourable impact8–10. For 75 
these reasons, individuals aged less than 18 years are not usually offered PST for adult-76 
onset disorders, the exceptions being if testing is considered to be in a child’s best 77 
interests4. Conversely, according to guidelines used in the United Kingdom (UK), 78 
people aged 16 or 17 years are presumed to be capable of consenting to their own 79 
medical treatment, and, in specific cases, children under 16 years who are adjudged to 80 
fully understand what is involved in a proposed intervention will also have the capacity 81 
to consent to that intervention11: in other European countries adolescents have access to 82 
medical treatment by law. In addition, it has been argued that young persons who are 83 
considered as adults on the age-based criterion of 18 years are not all necessarily truly 84 
autonomous9. There is no specific age when a person is able to give autonomous 85 
consent, but it is important to consider psychological maturity9 that is cumulative with 86 
age, life experience and cognitive development12, while maturity of judgement depends 87 
upon responsibility, temperance, and perspective12.  88 
Prior to testing, young adults (YA) need to be aware of the potential risk to them of 89 
hereditary cancer, and this is usually disclosed by their parents13–15. Prevalence and 90 
experiences of parental communication of BRCA results to children under the age of 25 91 
were described by Bradbury et al.16: 55% of parents (n=23/25) reported sharing family 92 
history and/or genetic risk with at least one child. Their results indicate that the 42.9% 93 
(n=18) of children in these families were learning of their potential genetic risk of 94 
cancer before the age of 18 and 57% (n=24) between 18 and 25 years of age. It came to 95 
light in that study that children of those with a BRCA variant learnt of their parent’s 96 
genetic test results many years before preventive interventions were indicated. In fact, 97 
in a study of 273 women tested for hereditary breast and ovarian cancer variant, 98 
Patenaude et al.13 noted that, although most children were told by their mother, the 99 
child’s age influenced the communication with offspring: they showed there was no 100 
significant difference between numbers of minors (14 to 17 years, 85%) and YA (18 to 101 
30 years, 92%) informed of the risk by their parents. Borry et al.4, in their paper on PST 102 
in asymptomatic minors, concluded that minors, considering their age and degree of 103 
maturity, are able to participate in decision-making and their opinions regarding PST 104 
should be taken into consideration. 105 
A systematic review17 on this topic indicated that many YA grew up with little or no 106 
information concerning their genetic risk and that parents had exerted pressure during 107 
the testing decision-making process. The experience of genetic counselling (GC) was 108 
either reported as an opportunity for discussing problems or associated with feelings of 109 
disempowerment. Moreover, emotional outcomes of disclosure did not correlate with 110 
test results. However, none of the studies retrieved were conducted in Italy or other 111 
South-European countries. To address this gap, we undertook a qualitative study based 112 
on grounded theory to explore the psychosocial implications of PST for hereditary 113 
cancer in Italian YA aged 18 to 30 years.  114 
MATERIALS AND METHODS 115 
This was a qualitative study in which we employed a grounded theory approach. This 116 
approach was specifically chosen to explore the experiences of YA from their own 117 
perspective, in this case the subjective meanings associated with being at risk for 118 
hereditary cancer and their involvement with a health care technology and clinical 119 
process for risk identification and reduction. This study received ethics approval both 120 
from Plymouth University Faculty Research Ethics Committee (14/15-324), and St. 121 
Orsola-Malpighi Hospital Ethical Board (132/2014/O/Oss). 122 
In order to follow YA through the process of GC, from referral to follow-up, a 123 
longitudinal study design was chosen. This enabled the authors to obtain data before 124 
these were altered by the YA’s contact with the genetic service, as well as providing the 125 
opportunity to assess how perceived needs, expectations, and knowledge changed over 126 
the period of contact. Each participant was interviewed on three separate occasions: one 127 
month before GC, and two weeks and six months respectively after GC. 128 
Recruitment and participants 129 
All participants were recruited at the Genetics Unit of St.Orsola-Malpighi Hospital 130 
(Bologna, Italy). Every new young consultand making an appointment for the cancer 131 
genetics clinic was contacted before the consultation via telephone and invited to take 132 
part in the study. Inclusion and exclusion criteria are presented in Figure 1. The process 133 
of recruitment, interviews and data analysis was ongoing until data saturation18 was 134 
reached and no new categories were emerging.  135 
Data collection 136 
Face-to-face interviews were organised with participants who responded to an invitation 137 
to be involved in the study. All interviews were performed by LG (a genetic nurse with 138 
training in counselling skills and five years of experience in GC), to ensure that the 139 
participants were subject to a constant interviewer effect. Each interview began with 140 
questions regarding demographic information. Later sections were designed to 141 
understand the attitudes of YA, to evaluate their cancer perception and psychological 142 
status and to explore the extent to which the parents’ influence had been important. In 143 
addition, questions were refined and amended over the course of the interviews to take 144 
into account possible theories emerging from the data. The interviews were performed 145 
with the participant only: any accompanying person was waiting outside. The 146 
interviews were written in Italian (English version in Supplementary file). Data were 147 
collected using a digital recording device and interviews were transcribed verbatim, 148 
with names and other identifying material altered to ensure confidentiality. 149 
Data analysis 150 
Data were analysed using the grounded theory method18: each interview was analysed 151 
as soon after transcription as possible. The software package NVivo, version 10 (QRS 152 
international, Pty, Ltd) was used to help organise the data. The primary author listened 153 
to the digital recordings and transcribed the interviews. Statements were subsequently 154 
coded (open coding) from the transcribed material. All the interviews were translated 155 
into English by LG and an expert translator and checked by DT to ensure accuracy of 156 
translation and sense, and so improve rigour. The first 21 interviews were sent to other 157 
co-authors (HS and LJ) to code independently to further ensure rigour and as there was 158 
substantial agreement, the remaining interviews were coded by LG. The codes and 159 
emerging categories derived by the co-authors were then compared to ensure 160 
trustworthiness of the findings. Any disagreements were discussed until consensus was 161 
reached. Finally, the data were further synthesised by grouping categories into major 162 
themes to establish the relationships between data from all participants (axial coding).  163 
RESULTS 164 
Seventeen invitations were sent to potential participants: 14 (82.4%) accepted and were 165 
interviewed (Figure 2). In total 42 interviews were conducted with 14 participants. The 166 
participant characteristics are presented in Tables 1 and 2. Respondent ages ranged from 167 
18 to 30, with a mean age of 25.3 years. The characteristics of the participants’ parents 168 
(based on information provided by the YA) are presented in a supplemental table.   169 
Four major themes were identified. The pseudonym and interview number with that 170 
participant (Int 1, 2 or 3) are included after each direct participant quote.  171 
Knowledge 172 
Many YA reported having grown up without awareness of or with misinformation about 173 
the hereditary cancer running in their family. Following their first GC appointment, 174 
some YA affirmed that as a result of the GC session their knowledge had improved: 175 
“Although the pathogenic gene contaminated the female organs, I thought my mom 176 
could have transmitted the pathogenic gene to me and it could have contaminated every 177 
single organ. At the beginning I was very confused.” (Mario, age 26, Int 2) 178 
Despite misinformation or lack of awareness, YA reported that the family history had 179 
an important role in terms of their awareness and that it affected their feelings. “Having 180 
a family member diagnosed with cancer definitely makes you more aware of cancer.” 181 
(Donato, age 30, Int 3). Another important issue for participants was realizing the need 182 
for surveillance. Some had not yet started any additional clinical surveillance that would 183 
have been relevant for the familial condition. “I want to prevent [...] I’ll do anything to 184 
stay healthy [...] I want to live!” (Barbara, age 29,Int 3). After GC, YA became aware 185 
of the options for clinical screening, and the possibility of having more frequent 186 
screening without undergoing PST: “It was not required to proceed to the standard 187 
routine of undergoing the exam, waiting for the results and then later entering the 188 
screening; but you could choose to take up screening” (Caterina, age 29, Int 2). 189 
Nevertheless, one young woman thought that cancer could occur even if the variant was 190 
not found and therefore she should have screening because of the family history: “My 191 
family history is that, despite the fact of having the syndrome or not.” (Morena, age 25, 192 
Int 1). Before GC, PST was described as ‘just a blood test’ by participants. Waiting for 193 
the PST result was another point emphasised by YA. Some reported that was the only 194 
thing they wanted to ask the genetic counsellor, for example, one young woman said: 195 
“At the end, I had only one question left and it was about the timing …. … I had no 196 
doubts … but only lack of knowledge” (Morena, age 25, Int 2). Also after the GC, the 197 
PST was often perceived as ‘a need to wait for the result’. One young woman, who 198 
experienced a pregnancy, had compared ‘the need to wait for the result’ with her 199 
experience of finding out her baby’s gender. Although at first YA did not really know 200 
what PST was, after GC they declared that they better understood what they were doing 201 
or better understood the importance of undergoing PST. “I truly understood (the 202 
meaning of it all) only after dealing with counselling and questions they asked me” 203 
(Barbara, age 29, Int 3). At the same time, YA regarded the PST as a medical test like 204 
any other. “An exam like any other. [...] It was an ordinary blood sample.” (Luca, age 205 
24, Int 2). Once aware of the family genetic disorder, those who did not understand 206 
what it really meant sought information online, while others did not want to use the 207 
Internet as a source of research. Nevertheless, YA preferred not to speak about their 208 
situation with friends. “Then I sincerely don’t want to analyse my private life too much 209 
with my friends.” (Mario, age 26, Int 1). Almost all YA were informed of their family 210 
genetic status by their mother. In cases where the mother was deceased, the person who 211 
had been genetically tested in the family often informed the young adult.   212 
Genetic counselling process 213 
The experience of the GC process was explored and YA explained their motivations to 214 
have it, their expectations and experience of it. Undergoing GC was motivated by 215 
curiosity, a need for information, and to obtain certainty. Others focused their attention 216 
on undergoing GC to help prevent cancer. The decision to undergo GC was not always 217 
specifically discussed with parents, but YA knew that their relatives had consulted 218 
medical professionals and wished to follow a similar pathway. Nevertheless, four 219 
participants underwent GC purely for themselves, for example Mario decided to go 220 
through GC: “For a more serene future.” (Mario, age 26, Int 1). One of the two YA 221 
with children underwent GC because of anxiety about her daughter, while some 222 
participants underwent GC to understand the risk to their future children. 223 
The majority of YA interviewed had no expectations about GC, mostly because they 224 
lacked knowledge about it. However, they still expected a blood test, as something that 225 
genetic counsellors suggested, something they had to do, and something that would be 226 
uncomfortable. “Counselling was the prelude of the genetic test [...] I didn’t think I 227 
could have said ’no’ at the end as well as any other person. [...] I thought it was a 228 
required step” (Morena, age 25, Int 2). Some YA perceived GC/PST as a ‘need to wait 229 
for the result’, and they were therefore surprised to have the blood sample taken at the 230 
first consultation. “I honestly didn’t expect to be tested during the first counselling.” 231 
(Barbara, age 29, Int 2). Young adults interviewed reported GC had helped them, 232 
through the process of discussion with the counsellor. Some positive feelings were 233 
expressed about genetic counsellors, such as the perception of being understood and that 234 
the counsellor was the person who explained the meaning of testing. Many YA reported 235 
that they had not expected to have a choice. They had assumed that, in agreeing to 236 
undergo the GC process, they would have a PST and they were surprised when they 237 
realized they make a testing decision. “At the end, they asked me if I wanted to do this 238 
thing. I thought counselling ended with the genetic test, instead it didn’t! It was the idea 239 
I had for months!” (Eleonora, age 30, Int 2). All the YA were offered, and underwent, 240 
PST at the first GC session except one, who was offered a second pre-test session. She 241 
declared she felt more aware of the implications of the test when she underwent it 242 
during the second session: “With hindsight I think the first time I’d have done it 243 
unconsciously. […] today, I’m more conscious about what I’m doing.” (Paola, age 25, 244 
Int 2). Even if they had already made a clear choice to undergo the PST before the 245 
consultation, some expressed a desire to have the genetic counsellor give an opinion to 246 
guide them.  247 
Decision-making for testing or not 248 
Although theoretically, making an autonomous choice to undergo PST is a fundamental 249 
requirement of the process of GC, some young family members were subject to pressure 250 
from their parents to be tested. As a consequence of parental pressure, some YA 251 
reported that they underwent PST for the sake of a parent/relative. “Honestly, because 252 
my mother told me and she did it first ... I'm doing it as a favor to her.” (Luca, age 24, 253 
Int 1). However, differences emerged in the extent of parental involvement in the 254 
decision-making process. In some cases, the decision to have a PST was made 255 
autonomously but was congruent with the relatives’ point of view. “I called to have an 256 
appointment under pressure from my mother … I’d have done it sooner or later. 257 
...although I would have chosen to wait a bit more.” (Angelica, age 24, Int 1). On the 258 
other hand, the decision was sometimes at odds with the parent’s opinion. “She 259 
(mother) has always been very uncertain whether to get me to do the project. She said: 260 
‘You have to think more deeply about it, the result doesn’t change’.” (Morena, age 25, 261 
Int1). The participants’ decision-making process occurred before the first GC session: 262 
no participant reported having GC to help facilitate their decision about testing. 263 
However, it was not clear whose idea it was to undergo PST. Some of them tried to 264 
align the decision to have counselling with their perception of the appropriate time to 265 
start clinical surveillance. The majority attended the GC session alone, however, even if 266 
the participant attended alone, the counselling session was often arranged by the 267 
participant’s mother, especially for young men. No differences emerged between those 268 
whose mothers had booked and those who booked themselves. Nevertheless, a young 269 
woman who had decided to bring her mother with her reported that “Having her there 270 
made me experience the counselling as way more touching” (Morena, age 25, Int 2). 271 
The majority of YA decided not to share the decision to undergo PST with their friends. 272 
Others decided to share it only with close friends because they felt that other people 273 
would not understand the complexities of the situation. As Barbara (age 29, Int 1) 274 
described:“None of my friends knows (what I’m doing) because I think these are very 275 
personal things and, knowing my friends, I’m afraid that some of them might think bad 276 
(of me) and then I would feel bad”. Looking back on their experience of PST, three 277 
participants expressed a desire for something different from what they had experienced. 278 
While Barbara suggested a YA support group to discuss experiences, share ideas, and 279 
provide emotional support, others proposed having more professional psychological 280 
support. 281 
Dealing with the result 282 
Some participants perceived PST as a source of tension, mostly before they underwent 283 
GC. As Dario (age 20, Int 3) described:“At the beginning, it is normal to feel a little bit 284 
scared or worried because it is something unknown ... but when everything is explained 285 
one calms down”. Some YA expected that the PST result would be negative. Others, 286 
who believed before testing that they would be variant-positive, felt relieved when the 287 
test had a different outcome. As Barbara (age 29, Int 1) described:“If I didn’t have the 288 
gene ... breathe”. However, the PST result was perceived by YA as useful in helping 289 
them to plan their lives. Conversely, others did not think that they would change their 290 
behaviour based on the possible result. However, when they considered how they might 291 
react, the majority affirmed that they did not know. 292 
Once aware of their test result, none of those interviewed reported a catastrophic 293 
emotional response: emotions of relief, happiness and fear were generally reported. 294 
Accordingly, participants with negative PST results described themselves and their 295 
parents as happy to have this knowledge. Regardless of the result, some YA felt they 296 
had matured as a result of their testing experience. Moreover, once they had received 297 
the result, they recommended that their relatives (e.g. siblings) undergo PST as well. 298 
Only Morena specifically recommended GC to her relatives. Changes in behaviour were 299 
not generally reported in either variant-positive or variant-negative YA, however, a 300 
young woman who was variant-positive started to pay more attention to her body and 301 
possible symptoms.  302 
Young women who were variant-positive, started their surveillance and one of them 303 
described herself ‘having butterflies’ (Barbara, age 29, Int 3) after her first screening, 304 
nervous about her first ultrasound outcome. Fortunately, it was normal and she felt 305 
relieved, but she underlined that the relief would last ‘until the next follow-up visit’. 306 
DISCUSSION 307 
The aim of this study was to investigate the experience of PST in Italian YA aged 18-30 308 
years. The choice of this range of age was made on the basis of the specific Italian 309 
context. In Italy, the age at which YA leave the parental home is very high when 310 
compared to other countries19,20. It is clear that the activities of young adulthood, e.g. 311 
forming partnerships and becoming parents, occur later than in other cultures 20 and this 312 
could affect their PST decision-making. 313 
The results show that participants grew up with little or no information about their 314 
genetic risk and they usually became aware of their risk less than one year before 315 
testing. This is in contrast with findings emerging from the papers reviewed in the 316 
systematic review17 where YA were informed several years before testing or clinical 317 
actions could be undertaken21–23. Considering the Italian context, this may be because of 318 
the delay of YA’s development into mature adulthood. At the time of the final 319 
interview, young adults were consciously, as well as unconsciously, developing 320 
strategies to cope with the experience they were facing. There was a dynamic 321 
relationship between the decision-making process and their autonomous choice: YA 322 
arrived at the decision-making process because of previous knowledge, disclosed by 323 
one or both parents. Consistent with this finding, a meta-synthesis of the family 324 
communication between children and their parents about inherited genetic conditions 325 
conducted by Metcalfe et al.24 showed that parents were primarily responsible for 326 
discussing genetic information with their children. Although there was a desire by 327 
parents to tell their children about their potential genetic risk before others told them24, 328 
parents also stressed delaying the disclosure or choosing the right time to talk25. No 329 
differences emerged between participants who underwent PST when they aged less than 330 
24 years and those who were older, whereas Hamilton26 reported that older YA were 331 
more likely than younger ones to decide autonomously to have PST. Young adults are 332 
normally at a stage of life in which they are acquiring knowledge about themselves and 333 
the world around them27,28. They may or may not be sufficiently mature, or have a 334 
realistic set of expectations about what genetic information will allow them to do, or 335 
even the health insurance to support risk management decision-making12,29. They may 336 
or may not fully understand the science behind PST related cancer risk, gene 337 
penetrance, or prevention. 338 
In this study, at the start of the GC process participants had often not understood that 339 
their choices had serious implications. Instead, as Lindenmeyer et al.30 underlined, 340 
participants did not choose to undergo PST separate from the collective concerns and 341 
desires of their families. Parents may exert pressure on YA children to complete PST31, 342 
however no participants reported the same behaviour as their parents in terms of risk 343 
management decisions (e.g. surgery rather than screening).  344 
Concerning the impact of test results, overall, our findings do not support a substantial 345 
risk of adverse emotional outcome in variant carriers, which is in agreement with 346 
previous findings32. In contrast, being variant-positive for Huntington disease may 347 
influence a YA’s education, career, relationships and family planning33. This may be 348 
because there is no preventive treatment available at present for that condition, or that 349 
the condition is perceived to have much greater impact on functioning throughout life.  350 
Overall, although our results may not be generalizable because of a lack of data from 351 
South-European countries, differences with other countries emerged. Further study in 352 
the Mediterranean area may be needed to clarify if these differences are peculiar to the 353 
Italian population or may be generalizable to other countries of this area. 354 
Strengths and limitations 355 
An identifiable strength of this study was the method chosen, which provided an 356 
effective framework for key themes to emerge from the data. Moreover, because of the 357 
longitudinal design we have been able to ascertain the views of young adults 358 
considering testing both prospectively and retrospectively. A limitation of this study is 359 
that we only identified YA who decided to undergo PST, as we were unable to recruit 360 
YA who decided not to be tested. Additionally, we were unable to affirm that our results 361 
are unique for the age group studied, the comparison with older age groups was not 362 
possible as it falls outside the aim of the present study. 363 
CONCLUSION 364 
The findings of this study indicate a need for further guidance on PST in these 365 
populations: it is important for health professionals to understand how much the YA 366 
involved are really aware of the implications before and after they have been tested. It is 367 
therefore important to publicise the supportive and educational role of genetic services. 368 
Moreover, appropriate communication of genetic risk information by parents to their 369 
children is highly desirable, since it has been shown to have long-term consequences24. 370 
To achieve this, health professionals could have a role in both supporting parents and 371 
YA, as their involvement in the parents’ decision to communicate genetic risk to young 372 
family members was found to be limited16,17,34,35. Although this may be partly due to the 373 
parents’ wish to undertake this task alone, it is reported that some parents desired health 374 
professionals to be available in a supporting role, but found this was limited24,36. This 375 
evidence highlights the need for a comprehensive, longitudinal counselling process with 376 
appropriate timing and setting, which supports ‘parent-to-offspring’ risk communication 377 
first and YA’s decision-making about PST and risk management afterwards. In 378 
conclusion, it is clear that GC approaches to this population may require modification 379 
both for YA and their parents. Further analysis is required to determine how YA and 380 
their parents interpret PST, how they experience GC, and the influence that parents have 381 
on YA’s decisions after the disclosure of the positive test result to inform GC practice in 382 
this client group. 383 
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FIGURE 1: INCLUSION AND EXCLUSION CRITERIA 
 
Participants were invited to take part in the study if they were: 
- aged 18-30 years 
- without personal history of cancer 
- members of families with a hereditary cancer predisposition 
- able to give informed consent, and  
- able to speak Italian or English fluently.  
Young adults were excluded from the study if they were: 
- clients counselled by the principal researcher  
- unable to provide informed consent, for example due to mental incapacity or active 
psychotic illness. 
FIGURE 2: THE RECRUITMENT PROCESS 
 
TABLE 1: DESCRIPTION OF PARTICIPANT CHARACTERISTICS 
GENDER N(%)  
 MALE 6 (42.9%) 
 FEMALE 8 (57.1%) 
AGE AT INTERVIEW (YEARS)  
 MEAN±SD 25.3±3.6 
COUNTRY OF BIRTH N(%)  
 ITALY 13 (92.9%) 
 POLAND 1 (7.1%) 
MOTHER’S LANGUAGE N(%)  
 ITALIAN 13 (92.9%) 
 POLISH 1 (7.1%) 
CONDITION TESTED FOR N(%)  
 BRCA1 8 (57.2%) 
 BRCA2 5 (35.7%) 
 MLH1 1 (7.1%) 
AGE AT TEST (YEARS)  
 MEAN±SD 25.3±3.6 
 RANGE 18-30 
RESULT N(%)  
 POSITIVE (FOR MUTATION) 4 (28.6%) 
 NEGATIVE (FOR MUTATION) 10 (71.4%) 
EDUCATION N(%)  
 MIDDLE SCHOOL QUALIFICATION 1 (7.1%) 
 HIGH SCHOOL DIPLOMA 7 (50.0%) 
 UNIVERSITY DEGREE 5 (35.8%) 
 POST-GRADUATE DEGREE 1 (7.1%) 
DAILY WORK N(%)  
 STUDENT 5 (35.8%) 
 WORKER 3 (21.4%) 
 EMPLOYEE 3 (21.4%) 
 BUSINESS OWNER 1 (7.1%) 
 UNEMPLOYED 2 (14.3%) 
MARITAL STATUS N(%)  
 MARRIED 1 (7.1%) 
 SINGLE 12 (85.8%) 
 LIVING TOGETHER 1 (7.1%) 
HAVING CHILDREN N(%)  
 NO 12 (85.7%) 
 YES 2 (14.3%) 
 










INTERVIEW  DURATION 
(MIN) 
Donato 30 
His mother was diagnosed with ovarian cancer when he was 26 years old.  One 
maternal aunt had breast cancer some years ago.  His mother was the first person 
in the family to have genetic testing and she discovered her result one year ago. 
 
He lives in various countries around the world because of his work. 
 
The interviews were very difficult to arrange due to challenges in communication 
and making time.   In fact the last interview was conducted by email. 
Mother Mother 
Int.1 – 14.21 
Int.2 – email 
Int.3 - email 
Barbara 29 
Her mother was diagnosed with ovarian cancer when she was 26 years.  On her 
mother’s side, her  grandmother and one aunt also had breast cancer. Her mother 
was the first person in the family to have genetic testing and she discovered her 
result two years ago. Both grandmother and aunt had genetic testing and both 
have BRCA mutations. 
 
She has lived in Italy since she was 20 years old. 
 
She gave the impression of being a very strong young woman, however she was 
accompanied by her mother at both interviews and counselling sessions. 
Mother Mother 
Int.1 – 38.51 
Int.2 – 10.54 
Int.3 – 44.35 
Morena 25 
Her mother was diagnosed with colon cancer when she was 8 years old, and with 
endometrial cancer when she was 19 years old.  On her mother’s side, her  
grandfather had colon cancer and his mother was diagnosed with gynaecological 
cancer.   Her mother was the first person in the family to have genetic testing and 
she discovered her result six years ago. 
 
She was accompanied by her mother at counselling sessions.  She also texted me 
to remind me about her interviews.  
Mother Mother 
Int.1 – 41.22 
Int.2 – 43.25 
Int.3 – 42.01 
Mario 26 His mother was diagnosed with breast cancer when he was 13 years old.  In the same period, a maternal aunt had breast cancer. Another maternal aunt had Mother Mother 
Int.1 – 22.53 
Int.2 – 24.23 
breast cancer when he was 20 years old.  His maternal grandmother died because 
of ovarian cancer when he was 22 years old.  His grandmother was the first 
person in the family to have genetic testing and his mother discovered her genetic 
status one year ago. 
 
He lives in a small city in the south of Italy. 
 
He texted me to remind me about his interviews, however he was accompanied 
by his mother and his maternal uncle at the counselling session.  His result was 
collected by his maternal uncle. 
Int.3 – 12.31
Angelica 24 
Her mother was diagnosed with breast cancer when she was 22 years old.  
Maternal grandmother died because of breast cancer.  Her mother was the first 
person in the family to have genetic testing and his mother discovered her genetic 
status one year ago. 
 
She came  alone to both interviews and counselling, however she forgot both her 
first counselling session and our second interview.   She only remembered after 
receiving an appointment reminder.  
Mother Mother 
Int.1 – 26.18 
Int.2 – 30.48 
Int.3 – 18.56 
Paola 25 
Two paternal aunts were diagnosed with breast cancer and another paternal aunt 
had ovarian cancer.   Grandmother died because of ovarian cancer.  Recently her 
father discovered his genetic status. 
 
She came  alone to both interviews and counselling sessions. 
Father Father and aunts (father’s side) 
Int.1 – 19.47 
Int.2 – 20.28 
Int.3 – 21.01 
Eleonora 30 
Her mother died because of breast cancer, as did two maternal aunts.  Her 
grandmother was the first person in the family to have genetic testing and she 
discovered her genetic status one years ago. 
 
She texted me to remind me about her interviews, however she was 
accompanied by her father both at interviews and at the counselling sessions.  
Although he was with her during the counselling, she never mentioned this.  
Mother 
(?) Cousin 
Int.1 – 22.55 
Int.2 – 28.41 
Int.3 – 24.21 
Luca 24 
His mother was diagnosed with breast cancer last year.  His maternal 
grandmother was diagnosed with ovarian cancer and breast cancer when he was 
20 years.  His grandmother was the first person in the family to have genetic 
testing and his mother discovered her genetic status one year ago. 
Mother Mother 
Int.1 – 10.01 
Int.2 – 11.56 
Int.3 – 12.35 
 
He was accompanied by a friend at the counselling sessions.  
 
The interviews were very difficult to arrange in terms of communication. 
Caterina 29 
Her mother was diagnosed with ovarian cancer when she was 27 years.  On her 
mother’s side, two aunts had breast cancer and grandmother had ovarian cancer.  
One aunt was the first person in the family to have genetic testing and mother 
discovered her genetic status two years ago. 
 
She came  alone to both interviews and counselling sessions. 
Mother Mother 
Int.1 – 25.40 
Int.2 – 24.07 
Int.3 – 26.09 
Emma 27 
Her mother was diagnosed with breast cancer when she was 25 years.  Maternal 
grandmother died because of breast cancer.  Her mother was the first person in 
the family to have genetic testing and his mother discovered her genetic status 
one year ago.  Some months before, her sister (Angelina here) was tested. 
 
She came alone to both interviews and counselling. 
Mother Mother 
Int.1 – 16.46 
Int.2 – 14.50 
Int.3 – 17.35 
Patrizia 23 
Her mother was diagnosed with breast cancer when she was 6 years old and with 
contralateral breast cancer when she was 20 years old. Her maternal aunt had 
breast cancer when she was 21.  Her mother was the first person in the family 
who had genetic testing and his mother discovered her genetic status two years 
ago. 
 
She was accompanied by maternal aunt both at interviews and counselling 
sessions. 
Mother Mother 
Int.1 – 17.51 
Int.2 – 10.51 
Int.3 – 24.20 
Dario 20 
His mother was diagnosed with breast cancer when he was 2 years and with 
contralateral breast cancer when he was 17 years old.  Both his maternal aunt 
and grandmother had breast cancer.  His mother was the first person in the family 
to have genetic testing and his mother discovered her genetic status one year 
ago. 
 
He was accompanied by his brother both at first interview and first counselling 
session.  He came alone to the post-test counselling and his brother delegated 
him to collect the brother’s genetic test result (in Italy this is not routine, but 
sometimes happens). 
Mother Mother 
Int.1 – 20.29 
Int.2 – 17.35 
Int.3 – 21.53 
Matteo 18 
His mother was diagnosed with breast cancer when he was 17 years old.  His 
mother was the first person in the family to have genetic testing and his mother 
discovered her genetic status one year ago. 
 
He was accompanied by a friend both at the interviews and at counselling 
sessions. 
Mother Mother 
Int.1 – 38.51 
Int.2 – 10.54 
Int.3 – 44.35 
Saverio 24 
Two maternal aunts were diagnosed respectively with breast cancer and ovarian 
cancer.  Recently his mother discovered her genetic status. 
 
The interviews were very difficult to arrange in terms of communication and time.  
Mother Mother 
Int.1 – 10.51 
Int.2 – 09.55 
Int.3 – 11.01 
 
 
